However, in bladder cancer, SOX2 stimulates IGF2 expression62, and with SOX2 elevation occurring due to androgen withdrawal, this may further elevate the transcription of IGF2 in NEPC. This evidence concerns the gene IGF2 and urinary bladder carcinoma.